
This content can be accessed for FREE when you register

Donald Trump has accused the UK of “freeloading” because the NHS is able to secure better prices for US drugs than the fragmented insurance-based system in the States. Consultant Neil Clothier explains how the NHS can steel itself against possible drug price hikes resulting from the US president’s plans to ‘even out’ these price differences.
to receive daily news from Public Finance International to your inbox